Researchers adapt CAR-T immunotherapy to target the HIV latent reservoir
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell. The work showcases a novel version of CAR-T, the ...
Oct 24, 2019
0
14